Methamphetamine and Psychosis: A Family Affair
Episode Overview
Dr. McKetin explores the influence of family history of psychosis on the risk of methamphetamine-related psychotic symptoms. The prevalence of methamphetamine use in Australia and its correlation with psychotic episodes is discussed. The methodology of the study, including the data analysis and key findings, is outlined. The clinical implications of the findings for intervention strategies and public health initiatives are addressed. Dr. McKetin shares her insights on the generalizability of the research and the next steps for intervention in this field.
We can no longer say, if you don't have a family history of psychosis, you're going to be fine. You're still at risk of having psychotic symptoms when you use methamphetamine. And I think that's a really critical finding for people out there who want to use this drug. They need to understand that they're not going to be immune to that risk.
What if your family history could predict your risk of methamphetamine-related psychosis? In this thought-provoking episode of Addiction Audio, host Ben Scher sits down with Dr. Rebecca McKetin to unpack her recent research on this very topic. They dive into the nuances of methamphetamine use in Australia, exploring how it varies globally and what that means for those at risk. Dr.
McKetin sheds light on the intricate link between family history of psychosis and the likelihood of developing psychotic symptoms when using methamphetamine. She explains that the risk isn’t static; it changes depending on whether individuals are actively using the drug or not. The discussion also touches on the potential progression to schizophrenia and the critical role treatment services play in mitigating these risks. Dr.
McKetin shares a range of interventions that could help address methamphetamine use and related mental health issues, emphasizing the importance of targeting both those with and without a family history of psychosis. This episode is a must-listen for anyone interested in understanding the complex interplay between genetics, substance use, and mental health.